Analysis of gene expression identifies differentially expressed genes and pathways associated with lymphatic dissemination in patients with adenocarcinoma of the esophagus

Annals of Surgical Oncology

Volumn 15, Issue 12, 2008, Pages 3459-3470

  Lagarde, S M ^a   Ver Loren Van Themaat, P E ^a   Moerland, P D ^a   Gilhuijs Pederson, L A ^a   Ten Kate, F J W ^a   Reitsma, P H ^b   Van Kampen, A H C ^a   Zwinderman, A H ^a   Baas, F ^a   Van Lanschot, J J B ^c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ARGININOSUCCINATE SYNTHASE;

ADULT; AGED; AMINO ACID METABOLISM; ANALYSIS; ARTICLE; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; FEMALE; GENE EXPRESSION; GENE SET ENRICHMENT ANALYSIS; HUMAN; HUMAN TISSUE; LIPID METABOLISM; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PROGNOSIS; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADULT; AGED; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 58149277496     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0165-y     Document Type: Article

References (50)

1. AA Botterweck LJ Schouten A Volovics 2000 Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries Int J Epidemiol 29 645 54
2. SS Devesa WJ Blot JF Fraumeni Jr 1998 Changing patterns in the incidence of esophageal and gastric carcinoma in the United States Cancer 83 2049 53
3. H Pohl HG Welch 2005 The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence J Natl Cancer Inst 97 142 6
4. J Wayman MK Bennett SA Raimes 2002 The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction Br J Cancer 86 1223 9
5. C Mariette JM Balon G Piessen 2003 Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease Cancer 97 1616 23
6. JB Hulscher JW van Sandick AG de Boer 2002 Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus N Engl J Med 347 1662 9
7. M Westerterp LB Koppert CJ Buskens 2005 Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction Virchows Arch 446 497 504
8. van't Veer, Dai H, Van de Vijver M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415:530-6
9. P Roepman A de Jager MJ Groot Koerkamp 2006 Maintenance of head and neck tumor gene expression profiles upon lymph node metastasis Cancer Res 66 11110 4
10. Lagarde SM, ten Kate FJ, Richel DJ, et al. Molecular prognostic factors in adenocarcinoma of the esophagus and gastroesophageal junction. Ann Surg Oncol 2007; 14(2):977-91
11. SM Lagarde FJ ten Kate JB Reitsma 2006 Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction J Clin Oncol 24 4347 55
12. T Lerut W Coosemans G Decker 2006 Diagnosis and therapy in advanced cancer of the esophagus and the gastroesophageal junction Curr Opin Gastroenterol 22 437 41
13. EP van Vliet MJ Eijkemans JW Poley 2006 Staging of esophageal carcinoma in a low-volume EUS center compared with reported results from high-volume centers Gastrointest Endosc 63 938 47
14. CJ Lightdale KG Kulkarni 2005 Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer J Clin Oncol 23 4483 9
15. F Bertucci S Salas S Eysteries 2004 Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters Oncogene 23 1377 91
16. MA Bidus JI Risinger GV Chandramouli 2006 Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarray Clin Cancer Res 12 83 8
17. L Xi J Lyons-Weiler MC Coello 2005 Prediction of lymph node metastasis by analysis of gene expression profiles in primary lung adenocarcinomas Clin Cancer Res 11 4128 35
18. E Tamoto M Tada K Murakawa 2004 Gene-expression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancer Clin Cancer Res 10 3629 38
19. P Roepman LF Wessels N Kettelarij 2005 An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas Nat Genet 37 182 6
20. A Subramanian P Tamayo VK Mootha 2005 Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles Proc Natl Acad Sci U S A 102 15545 50
21. T Yamabuki Y Daigo T Kato 2006 Genome-wide gene expression profile analysis of esophageal squamous cell carcinomas Int J Oncol 28 1375 84
22. R Luthra TT Wu MG Luthra 2006 Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation J Clin Oncol 24 259 67
23. S Wang M Zhan J Yin 2006 Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesis Oncogene 25 3346 56
24. Y Xu FM Selaru J Yin 2002 Artificial neural networks and gene filtering distinguish between global gene expression profiles of Barrett's esophagus and esophageal cancer Cancer Res 62 3493 7
25. J Helm SA Enkemann D Coppola 2005 Dedifferentiation precedes invasion in the progression from Barrett's metaplasia to esophageal adenocarcinoma Clin Cancer Res 11 2478 85
26. DF Ransohoff 2005 Bias as a threat to the validity of cancer molecular-marker research Nat Rev Cancer 5 142 9
27. JJ Chen RR Delongchamp CA Tsai 2004 Analysis of variance components in gene expression data Bioinformatics 20 1436 46
28. Huber W, von HA, Sultmann H, et al. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 2002; 18(Suppl 1):S96-104
29. RC Gentleman VJ Carey DM Bates 2004 Bioconductor: open software development for computational biology and bioinformatics Genome Biol 5 R80
30. S Michiels S Koscielny C Hill 2005 Prediction of cancer outcome with microarrays: a multiple random validation strategy Lancet 365 488 92
31. Ruschhaupt M, Huber W, Poustka A, et al. A compendium to ensure computational reproducibility in high-dimensional classification tasks. Stat Appl Genet Mol Biol 2004; 3:Article37
32. JD Storey R Tibshirani 2003 Statistical significance for genomewide studies Proc Natl Acad Sci U S A 100 9440 5
33. FP Peters MA Kara WD Rosmolen 2006 Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: a prospective study Am J Gastroenterol 101 1449 57
34. DN Wheatley 2005 Arginine deprivation and metabolomics: important aspects of intermediary metabolism in relation to the differential sensitivity of normal and tumour cells Semin Cancer Biol 15 247 53
35. M Pan HA Choudry MJ Epler 2004 Arginine transport in catabolic disease states J Nutr 134 2826S 9S
36. A Husson M Quillard A Fairand 1996 Hypoosmolarity and glutamine increased the beta-actin gene transcription in isolated rat hepatocytes FEBS Lett 394 353 5
37. BJ Dillon VG Prieto SA Curley 2004 Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation Cancer 100 826 33
38. Yoon CY, Shim YJ, Kim EH, et al. Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase. Int J Cancer 2007; 120(4):897-905
39. PN Cheng TL Lam WM Lam 2007 Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion Cancer Res 67 309 17
40. F Izzo P Marra G Beneduce 2004 Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies J Clin Oncol 22 1815 22
41. PA Ascierto S Scala G Castello 2005 Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies J Clin Oncol 23 7660 8
42. S L'Esperance I Popa M Bachvarova 2006 Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors Int J Oncol 29 5 24
43. J Helleman MP Jansen PN Span 2006 Molecular profiling of platinum resistant ovarian cancer Int J Cancer 118 1963 71
44. T Manoli N Gretz HJ Grone 2006 Group testing for pathway analysis improves comparability of different microarray datasets Bioinformatics 22 2500 6
45. Cheadle C, Becker KG, Cho-Chung YS, et al. A rapid method for microarray cross platform comparisons using gene expression signatures. Mol Cell Probes 2007; 21(1):35-46
46. T Sorlie Y Wang C Xiao 2006 Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms BMC Genomics 7 127
47. RJ Cerfolio AS Bryant 2006 Maximum standardized uptake values on positron emission tomography of esophageal cancer predicts stage, tumor biology, and survival Ann Thorac Surg 82 391 5
48. JD Luketich PR Schauer CC Meltzer 1997 Role of positron emission tomography in staging esophageal cancer Ann Thorac Surg 64 765 9
49. Flamen P, Lerut A, Van CE, et al. The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer. J Thorac Cardiovasc Surg 2000; 120:1085-92
50. Flamen P, Lerut A, Van CE, et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 2000; 18:3202-10